✦ LIBER ✦

Erratum: Antifungal prophylaxis in liver transplant recipients

✍ Scribed by Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 120 KB
Volume: 16
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.22097

No coin nor oath required. For personal study only.

✦ Synopsis

UNOS status 4 (life support in ICU) 146 6.3 (2.4-16.7) George 1997 ( 14 ) Donor CMV þ/recipient -146 4.8 (2.0-11.8) George 1997 ( 14 ) UNOS class I (life support in ICU) 172 3.5 (1.7-7.0) Winston 1999 ( 23 ) Fungal colonization at baseline 172 2.3 (1.2-4.3) Winston 1999 ( 23 ) Pretransplant SCr 3 mg/dL 168 1.4 (1.2-1.6) Collins 1994 ( 11 ) and Karchmer 1995 ( 17 ) Per mg/dl increase in pretransplantation bilirubin

📜 SIMILAR VOLUMES

Antifungal prophylaxis in liver transpla

Antifungal prophylaxis in liver transplant recipients

✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse

Valganciclovir for cytomegalovirus proph

Valganciclovir for cytomegalovirus prophylaxis in liver transplant recipients

✍ Jeong M. Park; Kathleen D. Lake; Robert J. Fontana 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

We thank Jain et al. for their interest and correspondence regarding our recently published study. 1 The authors note that the incidence of cytomegalovirus (CMV) disease in our retrospective study was much lower than that reported by others. As acknowledged in our article, we did not use routine sur

Adherence in liver transplant recipients

✍ Patrizia Burra; Giacomo Germani; Francesca Gnoato; Silvia Lazzaro; Francesco Pao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Adherence to a medical regimen has been defined as the extent to which a patient's behavior coincides with clinical prescriptions. In liver transplant patients, adherence to immunosuppressive therapy and to medical indications in general is crucial for short-and long-term outcomes. Nonadherence to i

Antifungal prophylaxis in liver transpla

Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis

✍ Mario Cruciani; Carlo Mengoli; Marina Malena; Oliviero Bosco; Giovanni Serpellon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

We performed a meta-analysis to determine whether antifungal prophylaxis decreases infectious morbidity and mortality in liver transplant patients. We searched for randomized trials dealing with prophylaxis with systemic antifungal agents. We used a fixed effect model, with risk ratio (RR) and 95% c

Cost-effectiveness of different strategi

Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients

✍ Ananya Das 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Cytomegalovirus (CMV) is an important cause of morbidity and mortality in liver transplant recipients and several different strategies of CMV chemoprophylaxis are in practice. A cost-effective analysis was performed to compare these strategies. A hypothetical cohort of liver transplant recipients wa

Hepatitis B in liver transplant recipien

Hepatitis B in liver transplant recipients

✍ Robert G. Gish; Timothy McCashland 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire